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Abstract 
Background: Hepatocellular carcinoma (HCC), the most common type of primary liver cancer, is a life-threatening 
disease worldwide. This study aimed to investigate the epidemiology and clinical features of HCC patients who 
referred to Omid hospital in Mashhad, northeast of Iran. Materials and Methods: In this cross-sectional 
retrospective study, we reviewed the medical records of patients who referred to Omid hospital – a cancer research 
center– in Mashhad from 1991 to 2012. Medical records of 29 patients with primary liver cancer were analyzed in 
this study. Records that had biopsy-proven HCC were included. Results: Of 25 eligible cases, 68% were male and 
the rest were female. The majority of HCC patients were in the 60-69 age group. The major histologic subtype of 
HCC was typical. Besides, 48% of cases had tumors in one lobe of their liver. The average time from treatment to 
death was about three months in 44% of patients. Conclusion: The age distribution and male preponderance of 
HCC patients observed in the present study were similar to the previous studies carried out in Iran and other 
countries. Since this is a retrospective study, we recommend a comprehensive study such as cohort or case-control 
by including a larger sample size in which other HCC-related factors can be considered to investigate the etiology of 
HCC in the northeast of Iran. 
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Hepatocellular carcinoma (HCC) as a primary 
liver malignancy, is the fifth most common cancer 
worldwide (1, 2). HCC is responsible for 5% of all 
malignant tumors in the human and it is the ninth 
cause of cancer-related deaths in the world (3) which 
is associated with 300,000 to 500,000 deaths per year 
(4). It is estimated that the average survival is 
approximately 1 to 60 months, depending on the stage 
of HCC(5).   
Several previous studies have consistently 
reported that males have higher rates of HCC 
development than females, with a ratio of 2:1 (6). 
Also, the prevalence of HCC is over than twice in 
developing countries than the developed countries(2). 
The HCC distribution among regions of a 
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country depends on exposure to hepatitis B virus 
(HBV), hepatitis C virus (HCV) and other 
environmental risk factors. Determination of the 
etiologic agents may help to improve the surveillance 
of HCC patients. The most frequent underlying 
factors for developing HCC are chronic liver disease 
and cirrhosis, which are often associated with HBV 
and HCV infections (7). Indeed, ample literature has 
been published on the HCV and HBV-related HCC. 
Globally, it is estimated that around 350 million 
people are carriers of HBV. On the other hand, the 
HBV and HCV can easily spread via blood 
transfusions and the sharing of injecting equipment, 
which can increase the risk of developing HCC (8). 
Intake of metabolic toxins (such as alcohol or 
aflatoxin), smoking, obesity, and other infections like 
Schistosomiasis are additional risk factors for 
developing HCC (9).  Our study aimed to assess the 
epidemiology and clinical features of HCC patients 
admitted to the largest referral cancer center in 
Mashhad. 
Methods 
This cross-sectional study was conducted 
between the years 1991 and 2012. The medical 
records of 25810 patients who admitted to Omid 
hospital, a major referral cancer research center in 
eastern Iran, were reviewed. We found 29 patients 
with HCC. All HCC patients who were confirmed 
through liver biopsy were included in the study. 
Consequently, four patients were excluded from the 
analysis due to a lack of availability of pathology 
records. Twenty-five subjects were analyzed for age, 
sex, histological subtypes of HCC, hepatitis B 
surface antigen (HBs Ag) status, number of the 
involved liver lobe. According to the information 
available in the medical records, all the participants 
were followed up by telephone contact to obtain the 
outcome of treatment including the meantime from 
treatment to relapse, and the meantime from 
treatment to death. Data were analyzed by SPSS 
version 20 (SPSS Inc., IL, USA) and the ANOVA 
method.  
Results 
As shown in Table 1, 68% (n=17) of patients 
were male and 32% (n=8) were female, therefore, 
according to the results of the present study, the 
patients were predominantly male, with a male-female 
ratio of 2.1:1. 
Of the 25 patients, 36% (n=9) were in their 60-
69 years of age, 20% (n=5) of them were in the age 
group of 40-49 years, 16% (n=4) were under 40 years 
of age, 12% (n=3) were in the age group of 50-59 
years, 16% (n=2) of patients were in age between  70-
79 years and 16% (n=2) had more than 80 years.  
Eleven individuals were found to be HBsAg 
positive. But the HBsAg status of 9 patients was not 
reported. Furthermore, as illustrated in Table 1, the 
histologic subtypes of HCC were as follows: 88% 
typical, 8% clear cell, and 4% FLC. It should be noted 
that no other histological features were found. 
Moreover, 48% of patients’ tumors were restricted to 
one lobe of the liver, and 44% had both lobes 
involvement.   
Table 1. Patient characteristics  
P-
value 
Percent Number Variables 
0.009 68 17 Mmale Sex 
 32 8 Female 




 20 5 40-49 
12 3 50-59 
36 9 60-69 
8 2 70-79 
8 2 Up 80 
0.003 44 11 Positive HBsAg 
status 20 5 Negative 
36 9 Unknown 
0.022 8 2 Clear cell Histologic subtypes 
88 22 Normal 
4 1 FLC 
0.013 48 12 One Number of liver 
lobe involvement 
44 11 Two 
8 2 Unknown 
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         Follow up findings showed that 56% of patients 
had no recovery in terms of average time from the 
treatment of HCC to relapse. Besides, relapses were 
reported in 8% and 4% of patients after 12 and 18 
months, respectively (Table 2). Table 3 also shows 
the frequency of HCC cases based on the average 
time from treatment to death. 
 
Table 2. Frequency of HCC patients categorized by the 
average time from treatment to relapse 
Frequency (n 
(%)) 
Average time from treatment to 
relapse 
14 (56) No recovery 
2 (8) 12 months 
1 (4) 18 months 
1 (4) 24 months 
7 (28) Undetermined 
 
Table 3. Frequency of HCC patients categorized by the 
average time from treatment to death 
Frequency (n 
(%)) 
Average time from treatment to 
death 
11 (44) 3 months 
2 (8) 6 months 
1 (4) 12 months 
1 (4) 18 months 
1 (4) 24 months 
1 (4) 36 months 
7 (28) Undetermined 
1 (4) Alive 
 
Discussion 
        Globally, HCC is the fifth and seventh most 
common cancer in males and females, respectively. 
Moreover, HCC is the most common cancer which 
leads to death after lung and stomach cancers (1). A 
number of previous studies have reported that the 
HCC is more common in many regions of the world, 
such as parts of East Asia and sub-Saharan Africa than 
North America and some parts of Europe (10). This 
variation appears to be related to the geographic 
pattern or on etiologic factors in different regions. The 
age distribution of HCC patients and also male 
preponderance in the present study was in parallel with 
previous studies in Iran and other countries (1, 11-13). 
Since in the current study the HBsAg status of nine 
samples was not reported, therefore, the relationship 
between HCC and HBV infection cannot be deduced. 
          Regard to the relationship between HCC and 
viral hepatitis, we found that Khorasan Razavi 
province can be classified as one of a relatively low-
risk area in the world, because of the prevalence of 
HBV infection and HBs Ag among the Iranian 
population are approximately 2.2% (14) and 1.84% 
(15), respectively. Also, the legal and religious 
limitations of alcohol consumption (one of the HCC 
risk factors) in Iran can be another reason for the low 
prevalence of HCC. Moreover, it may be due to the 
patients who had not referred to Omid hospital. 
       We acknowledge the limitations of our study due 
to the retrospective nature of the data collection. The 
incomplete medical records especially laboratory and 
imaging tests should be considered in future research. 
Prospective multicenter studies would be of great 
interest in this regard. Therefore, we need further 
studies with a larger sample size in a case-control 
study to evaluate the p-value for HCC related-risk 
factors. Also, it is needed to identify other HCC-
related factors such as HCV infection, alcohol or 
aflatoxin intake, smoking, hemochromatosis, and 
levels of androgenic hormones to understand the major 
causes of the HCC.  
Conclusion 
         This study revealed that HCC was more 
prevalent in men than women, especially in the age 
group of 60-69 years old. The most histological 
feature of HCC tumors, in our patients, was typical 
subtype. However, further research is necessary to 
identify the clinical characteristics and trends of HCC 
among the Iranian population.  
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